NCT06192927: An ongoing trial by Causeway Therapeutics
This trial is ongoing. It must report results 2 months, 2 weeks from now.
Full data
| Full entry on ClinicalTrials.gov | NCT06192927 |
|---|---|
| Title | A Phase 2, Multi-Centre, Randomised, Double-Blind, Sham Controlled Proof of Concept Trial Evaluating the Efficacy and Safety of TenoMiR by Injection in Subjects With Lateral Epicondylitis |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | April 10, 2024 |
| Completion date | March 3, 2025 |
| Required reporting date | March 3, 2026, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |